Es gab 50 kürzliche Insider-Transaktionen für Vera Therapeutics, Inc. (VERA), darunter 28 Käufe und 18 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $27.59M und die gesamten Insider-Verkäufe auf $4.28M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Wright-mitchell Jane, Young Joseph R, Hite Christopher. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — VERA
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2026-03-23 |
Wright-mitchell Jane |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2026-03-23 |
Wright-mitchell Jane |
Chief Legal Officer |
RSU-Zuteilung |
42,403 |
- |
- |
42,403 |
| 2026-03-13 |
Young Joseph R |
SVP, Finance, Chief Acct Offcr |
Optionsausübung (Verkauf) |
10,000 |
$3.94 |
$39.4K |
38,589 |
| 2026-03-05 |
Hite Christopher |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2026-03-05 |
Hite Christopher |
Director |
RSU-Zuteilung |
24,937 |
$38.85 |
$968.8K |
24,937 |
| 2026-02-23 |
Johnson David Lee |
Chief Operating Officer |
Informierter Verkauf |
2,579 |
$41.98 |
$108.28K |
45,727 |
| 2026-02-23 |
Turner William D. |
Chief Regulatory Officer |
Informierter Verkauf |
2,187 |
$41.98 |
$91.82K |
45,313 |
| 2026-02-23 |
Fordyce Marshall |
President and CEO |
Informierter Verkauf |
16,925 |
$41.98 |
$710.58K |
257,163 |
| 2026-02-23 |
Young Joseph R |
SVP, Finance, Chief Acct Offcr |
Informierter Verkauf |
3,117 |
$41.98 |
$130.86K |
64,722 |
| 2026-02-23 |
Grant Sean |
Chief Financial Officer |
Informierter Verkauf |
4,949 |
$41.98 |
$207.78K |
114,181 |
| 2026-02-23 |
Brenner Robert |
Chief Medical Officer |
Informierter Verkauf |
2,151 |
$41.98 |
$90.31K |
50,947 |
| 2026-02-23 |
Skelton Laurence Matthew |
Chief Commercial Officer |
Informierter Verkauf |
1,582 |
$41.98 |
$66.42K |
64,218 |
| 2026-02-04 |
Johnson David Lee |
Chief Operating Officer |
RSU-Zuteilung |
40,000 |
$42.74 |
$1.71M |
40,000 |
| 2026-02-04 |
Turner William D. |
Chief Regulatory Officer |
RSU-Zuteilung |
25,000 |
- |
- |
47,500 |
| 2026-02-04 |
Fordyce Marshall |
President and CEO |
RSU-Zuteilung |
137,500 |
$42.74 |
$5.88M |
137,500 |
| 2026-02-04 |
Young Joseph R |
SVP, Finance, Chief Acct Offcr |
RSU-Zuteilung |
20,000 |
$42.74 |
$854.8K |
20,000 |
| 2026-02-04 |
Grant Sean |
Chief Financial Officer |
RSU-Zuteilung |
50,000 |
$42.74 |
$2.14M |
50,000 |
| 2026-02-04 |
Brenner Robert |
Chief Medical Officer |
RSU-Zuteilung |
50,000 |
$42.74 |
$2.14M |
50,000 |
| 2026-02-04 |
Skelton Laurence Matthew |
Chief Commercial Officer |
RSU-Zuteilung |
40,000 |
$42.74 |
$1.71M |
40,000 |
| 2026-01-20 |
Skelton Laurence Matthew |
Chief Commercial Officer |
Unbekannt |
31,500 |
$29.18 |
$919.17K |
- |
| 2025-12-15 |
Turner William D. |
Chief Regulatory Officer |
Informierter Verkauf |
10,000 |
$50.08 |
$500.77K |
22,500 |
| 2025-12-11 |
Enright Patrick G |
Director |
Informierter Kauf |
5,882 |
$42.50 |
$249.99K |
5,882 |
| 2025-12-08 |
Turner William D. |
Chief Regulatory Officer |
Informierter Verkauf |
10,000 |
$45.31 |
$453.05K |
22,500 |
| 2025-12-03 |
Turner William D. |
Chief Regulatory Officer |
Informierter Verkauf |
10,000 |
$40.00 |
$400K |
22,500 |
| 2025-11-25 |
Meyers James R |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2025-11-25 |
Meyers James R |
Director |
RSU-Zuteilung |
25,000 |
$29.43 |
$735.75K |
25,000 |
| 2025-11-21 |
Carter Jason S |
Chief Legal Officer |
Informierter Verkauf |
3,864 |
$27.82 |
$107.5K |
49,136 |
| 2025-11-13 |
Young Joseph R |
SVP, Finance, Chief Acct Offcr |
Optionsausübung (Verkauf) |
10,000 |
$3.94 |
$39.4K |
48,589 |
| 2025-11-11 |
Young Joseph R |
SVP, Finance, Chief Acct Offcr |
Informierter Verkauf |
15,000 |
$29.06 |
$435.87K |
47,839 |
| 2025-06-24 |
Enright Patrick G |
Director |
Informierter Kauf |
13,536 |
$22.35 |
$302.55K |
1,797,619 |
| 2025-06-23 |
Enright Patrick G |
Director |
Informierter Kauf |
69,798 |
$20.87 |
$1.46M |
1,784,083 |
| 2025-05-14 |
Seidenberg Beth C |
Director |
RSU-Zuteilung |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-05-14 |
Morrissey Michael |
Director |
RSU-Zuteilung |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-05-14 |
Enright Patrick G |
Director |
RSU-Zuteilung |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-05-14 |
Morrison Scott W |
Director |
RSU-Zuteilung |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-05-14 |
Katabi Maha |
Director |
RSU-Zuteilung |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-05-14 |
Cheng Andrew |
Director |
RSU-Zuteilung |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-05-14 |
Oliger Christy J. |
Director |
RSU-Zuteilung |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-05-14 |
Hall Kimball |
Director |
RSU-Zuteilung |
14,000 |
$21.19 |
$296.66K |
14,000 |
| 2025-02-26 |
Fordyce Marshall |
President and CEO |
Informierter Verkauf |
1,100 |
$28.32 |
$31.15K |
204,665 |
| 2025-02-21 |
Fordyce Marshall |
President and CEO |
Informierter Verkauf |
10,613 |
$27.89 |
$296.03K |
213,740 |
| 2025-02-18 |
Johnson David Lee |
Chief Operating Officer |
RSU-Zuteilung |
26,900 |
- |
- |
26,900 |
| 2025-02-18 |
Turner William D. |
Chief Development Officer |
RSU-Zuteilung |
22,500 |
- |
- |
22,500 |
| 2025-02-18 |
Fordyce Marshall |
President and CEO |
RSU-Zuteilung |
161,500 |
$29.18 |
$4.71M |
161,500 |
| 2025-02-18 |
Young Joseph R |
SVP, Finance, Chief Acct Offcr |
RSU-Zuteilung |
21,500 |
$29.18 |
$627.37K |
21,500 |
| 2025-02-18 |
Grant Sean |
Chief Financial Officer |
RSU-Zuteilung |
53,800 |
$29.18 |
$1.57M |
53,800 |
| 2025-02-18 |
Brenner Robert |
Chief Medical Officer |
RSU-Zuteilung |
26,900 |
- |
- |
27,474 |
| 2025-01-08 |
Fordyce Marshall |
President and CEO |
Informierter Verkauf |
9,975 |
$41.53 |
$414.3K |
143,603 |
| 2024-12-19 |
Fordyce Marshall |
President and CEO |
Optionsausübung |
57,661 |
$2.90 |
$167.03K |
143,603 |
| 2024-12-18 |
Fordyce Marshall |
President and CEO |
Informierter Verkauf |
3,772 |
$41.33 |
$155.88K |
85,942 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall
